Bridgefront Capital’s Akero Therapeutics AKRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-10,736	Closed	-$435K	–	588
2025 Q1	$435K	Buy	+10,736	New	+$435K	0.13%	293
2021 Q3	–	Sell	-12,099	Closed	-$300K	–	313
2021 Q2	$300K	Buy	+12,099	New	+$300K	0.11%	341